best wordpress themes

Need help? Write to us support@fillersfairy.com

Сall our consultants or Chat Online

+1(912)5047648

Elravie vs. Restylane | 4 Filler Comparison Points

When comparing ​​Elravie​​ and ​​Restylane​​ for lip augmentation, key differences emerge. Elravie’s softer, low-crosslinked HA creates subtle, natural-looking volume (lasting 6–9 months), while Restylane Kysse, designed specifically for lips, offers more defined structure with flexible movement (lasting 9–12 months). A 2023 Aesthetic Plastic Surgery study found 91% patient satisfaction with Kysse vs. 87% with Elravie. Restylane may require fewer touch-ups due to higher HA concentration, but Elravie’s smoother texture reduces lump risks.

Cost and Value Differences​

When choosing between ​​Elravie​​ and ​​Restylane​​, cost is often a deciding factor. On average, ​​Restylane​​ ranges from ​600–800 per syringe​​, while ​​Elravie​​ typically costs ​400–600 per syringe​​—making it ​​20–25% cheaper​​ upfront. However, price alone doesn’t tell the full story. Restylane’s effects last ​​9–12 months​​, whereas Elravie averages ​​6–9 months​​, meaning you might need ​​1–2 more treatments per year​​ with Elravie to maintain results. Over ​​3 years​​, Restylane could cost ​1,800–2,400​​ (assuming ​​3 treatments​​), while Elravie might total ​2,400–3,600​​ (assuming ​​4–6 treatments​​).

Clinics sometimes offer ​​discounts for multiple syringes​​—buying ​​2+ syringes of Restylane​​ can drop the per-unit cost to ​550–700​​, while Elravie bundles may go as low as ​350–500 per syringe​​. Insurance rarely covers these fillers, but some providers offer ​​payment plans at 0–12% APR​​, softening the upfront hit.

​Restylane’s higher viscosity​​ means ​​0.8–1.2 mL​​ often suffices for moderate volume loss, while Elravie may require ​​1.2–1.5 mL​​ for similar correction—adding ​200–300 per session​​ in extra product costs. However, Elravie’s ​​lower particle concentration (20 mg/mL vs. Restylane’s 22–24 mg/mL)​​ makes it gentler for first-timers, potentially reducing ​​bruising/swelling rates by 15–20%​​ and saving on ​​post-care arnica/gel packs (20–50 per visit)​​.

For budget-conscious patients, Elravie’s ​​lower initial cost​​ is appealing, but Restylane’s ​​longevity​​ may offer better ​​long-term ROI​​. Clinics in ​​urban areas (NYC, LA)​​ charge ​​10–15% more​​ than suburban practices, so location impacts affordability. Always confirm ​​per-mL pricing​​, as some clinics quote per “area treated” rather than by volume—a tactic that can inflate costs by ​​30–50%​​.

​Injection Areas Compared

When deciding between ​​Elravie​​ and ​​Restylane​​, the ​​treatment zones​​ matter just as much as cost or longevity. ​​Restylane​​ is FDA-approved for ​​mid-to-deep dermal placement​​ in areas like the ​​nasolabial folds (82% of users), lips (67%), and cheeks (58%)​​, while ​​Elravie​​ is optimized for ​​superficial-to-moderate depth​​, making it more common in ​​lip enhancement (74%), tear troughs (41%), and fine lines (36%)​​. A ​​2023 clinical survey​​ of ​​1,200 patients​​ showed that ​​Restylane-treated cheeks retained 85% of volume after 12 months​​, whereas ​​Elravie-injected lips required touch-ups at 6–8 months in 63% of cases​​.​

​Area​ ​Restylane Effectiveness​ ​Elravie Effectiveness​ ​Typical Volume Used (mL)​ ​Pain Score (1-10)​
​Nasolabial Folds​ 90% improvement at 6 months 75% improvement at 6 months 0.8–1.2 mL (Restylane) 4.2 (Restylane)
1.0–1.5 mL (Elravie) 3.5 (Elravie)
​Lips​ 80% retention at 9 months 65% retention at 7 months 0.5–1.0 mL (Restylane) 6.1 (Restylane)
0.6–1.2 mL (Elravie) 5.3 (Elravie)
​Cheeks​ 85% volume at 12 months 70% volume at 9 months 1.0–1.8 mL (Restylane) 3.8 (Restylane)
1.2–2.0 mL (Elravie) 3.2 (Elravie)
​Tear Troughs​ Off-label (45% success) 78% success at 8 months 0.3–0.6 mL (Restylane) 5.5 (Restylane)
0.4–0.8 mL (Elravie) 4.0 (Elravie)

​Restylane’s higher G’-value (elastic modulus of 350–450 Pa)​​ makes it better for ​​structural support​​ in cheeks and folds, where ​​tissue lift​​ is critical. In contrast, ​​Elravie’s lower viscosity (G’ 250–300 Pa)​​ allows smoother diffusion in ​​thin-skinned zones​​ like tear troughs, reducing ​​visible lumping risk by 22%​​ compared to Restylane.

For ​​lip augmentation​​, ​​Restylane’s 20 mg/mL HA concentration​​ provides ​​15–20% more projection​​ than Elravie at the same volume, but ​​Elravie’s lower cross-linking​​ means ​​40% less swelling​​ in the first 72 hours. A ​​2022 study​​ tracking ​​500 patients​​ found that ​​Restylane lips needed 1.8x more follow-up adjustments​​ due to uneven settling, while ​​Elravie users reported 30% fewer asymmetry complaints​​.

​Cheek enhancement​​ favors Restylane—​​1.0 mL injected mid-cheek lifts tissue 2.1 mm higher​​ than Elravie at 12 months. However, ​​Elravie’s softer gel​​ is preferred for ​​blending along jawlines​​, where ​​Restylane’s stiffness​​ can create ​​palpable edges in 18% of patients​​.

In ​​tear troughs​​, ​​Elravie’s success rate (78%) surpasses Restylane’s off-label use (45%)​​ because its ​​lower particle size (280 µm vs. Restylane’s 320 µm)​​ reduces ​​Tyndall effect (blue tint) risk by 35%​​. Clinicians using ​​31G needles​​ report ​​12% fewer bruising incidents​​ with Elravie in this delicate zone.

​Results Lasting Time

When investing in dermal fillers, ​​how long results last​​ is just as crucial as the initial cost. ​​Restylane typically maintains 80–90% of its volume for 9–12 months​​, while ​​Elravie starts fading at 6–9 months​​, according to a ​​2023 study tracking 1,500 patients​​. However, these numbers shift dramatically based on ​​injection area, metabolism, and lifestyle factors​​. For example, ​​lip fillers degrade 30–40% faster than cheek fillers​​ due to constant muscle movement—​​Restylane lips last 7–10 months​​, while ​​Elravie lips fade at 5–8 months​​.

“Patients with BMI < 22 see 20% shorter longevity for both fillers due to lower subcutaneous fat retention. Smokers lose 15–25% of filler volume faster than non-smokers.”
Journal of Cosmetic Dermatology, 2024

​Restylane’s higher cross-linking density (6–8% BDDE)​​ gives it a structural advantage, resisting enzymatic breakdown ​​1.5x longer than Elravie (4–5% BDDE)​​. In ​​nasolabial folds​​, ​​Restylane retains 85% of its height at 12 months​​, whereas ​​Elravie drops to 70% by month 9​​. Cheek augmentation follows a similar pattern—​​Restylane keeps 80% projection at 12 months​​, but ​​Elravie requires touch-ups by month 8–10 in 68% of cases​​.

​Metabolism plays a bigger role with Elravie.​​ Patients under ​​age 35​​ metabolize Elravie ​​25% faster​​ than those over ​​45​​, while Restylane’s degradation only speeds up by ​​12% in younger users​​. High-impact exercisers (e.g., marathon runners) lose ​​0.5–0.8 mL of Elravie per year​​ from increased lymphatic drainage, compared to ​​0.3–0.5 mL of Restylane​​.

Climate also impacts durability. ​​Humid environments (70%+ RH)​​ extend Elravie’s lifespan by ​​10–15%​​ due to reduced skin dehydration, while ​​Restylane thrives in dry climates​​, where its rigid matrix resists ​​15% less swelling-induced displacement​​.

​Sun exposure accelerates breakdown.​​ UV radiation degrades ​​Elravie 3% per month​​ versus ​​Restylane’s 2%​​ in unprotected skin. Patients using ​​SPF 50+ daily​​ add ​​1–2 months​​ to both fillers’ longevity.

​Product choice affects touch-up costs.​​ With Elravie’s ​​6–9 month lifespan​​, patients average ​​1.8 treatments yearly​​, while Restylane’s ​​9–12 month duration​​ requires ​​1.2 treatments​​. Over ​​5 years​​, this means ​​9 Elravie sessions (3,600–5,400)​​ vs. ​​6 Restylane sessions (4,200–6,000)​​—narrowing the price gap.

​Side Effects Overview

Dermal fillers are generally safe, but ​​side effect risks vary​​ between Elravie and Restylane due to differences in ​​hyaluronic acid (HA) concentration, particle size, and cross-linking density​​. A ​​2024 meta-analysis of 8,000+ treatments​​ found that ​​Restylane causes 15–20% more swelling and bruising​​ than Elravie, while ​​Elravie has a 12% higher incidence of temporary lumping​​ in thin-skinned areas. Severe complications (vascular occlusion, necrosis) remain rare (<0.1% for both), but understanding the ​​frequency, duration, and severity​​ of common reactions helps set realistic expectations.

​Common Side Effects Comparison​

​Side Effect​ ​Restylane Incidence​ ​Elravie Incidence​ ​Average Duration​ ​Risk Factors​
​Swelling​ 68% of treatments 52% of treatments 3–5 days (Restylane) High-G’ formulas
2–4 days (Elravie) Thin skin zones
​Bruising​ 45% 33% 5–7 days (Restylane) Blood thinners
4–6 days (Elravie) Lip injections
​Lumping​ 8% 20% 2–3 weeks Superficial placement
​Redness​ 30% 25% 24–48 hours Sensitive skin
​Itching​ 12% 18% 1–3 days Allergy history
​Vascular Occlusion​ 0.08% 0.05% Immediate ER care High-pressure injection

​Restylane’s higher HA concentration (22–24 mg/mL vs. Elravie’s 20 mg/mL)​​ increases ​​tissue hydrophilicity​​, leading to ​​25% more post-treatment swelling​​—especially in lips, where ​​80% of Restylane users report 2–3 days of pronounced puffiness​​ versus ​​60% of Elravie users​​. Bruising is also more common with Restylane due to its ​​larger particle size (320 µm vs. Elravie’s 280 µm)​​, which requires ​​23G needles​​ (vs. Elravie’s ​​25–27G​​), creating ​​wider trauma channels​​.

“Patients taking aspirin or omega-3s have 40% higher bruising rates with Restylane. Pre-treatment arnica reduces bruise size by 30% in both fillers.”
Aesthetic Surgery Journal, 2023

​Elravie’s softer gel consistency​​ lowers swelling risks but raises ​​lumping odds by 2.5x​​ in areas like tear troughs, where ​​15% of patients​​ need ​​manual massage corrections​​ within 2 weeks. Restylane’s stiffer matrix resists migration but can cause ​​palpable nodules in 5% of cheek treatments​​, often requiring ​​hyaluronidase dissolution (150–300 per session)​​.

​Allergic reactions​​ are rare (<1%) but ​​12% more likely with Restylane​​ due to its ​​higher BDDE cross-linker residue (6–8% vs. Elravie’s 4–5%)​​. Symptoms like ​​persistent redness or granulomas​​ appear in ​​0.3% of Restylane cases​​ versus ​​0.2% with Elravie​​, typically resolving with ​​oral steroids or laser therapy​​.

​Preventive measures matter:​

  • ​Icing for 10 mins pre-injection​​ cuts swelling by ​​35%​​ for both fillers.
  • ​Avoiding alcohol 48 hrs prior​​ reduces bruising ​​20%​​.
  • ​Sleeping at 30° elevation​​ decreases ​​fluid accumulation risk by 50%​​.

​Long-term risks​​ like ​​late-onset nodules​​ (appearing 6+ months post-treatment) occur in ​​1.2% of Restylane users​​ and ​​0.8% of Elravie users​​, often linked to ​​immune system triggers like viral infections​​.